26 Recruiting Studies Using Sunitinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Sunitinib
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
📍 University of Colorado Cancer Center — Aurora, Colorado
Cancer
View Study & Checklist ➔Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
📍 Stanford School of Medicine — Stanford, California
Renal Cell Carcinoma
View Study & Checklist ➔Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Prostate Cancer
View Study & Checklist ➔Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
📍 ECOG-ACRIN Cancer Research Group — Philadelphia, Pennsylvania
Advanced Lymphoma
View Study & Checklist ➔Savolitinib vs. Sunitinib in MET-driven PRCC.
📍 Research Site — La Jolla, California
Carcinoma
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Lymphoma
View Study & Checklist ➔A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
📍 Mayo Clinic Scottsdale — Scottsdale, Arizona
Gastrointestinal Stromal Tumors
View Study & Checklist ➔Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
📍 Exelixis Clinical Site #1 — Duarte, California
Non-Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
📍 Tom Baker Cancer Centre — Calgary, Alberta
Advanced Rare Tumours
View Study & Checklist ➔Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
📍 Moffitt Cancer Center — Tampa, Florida
Thymic Carcinoma
View Study & Checklist ➔Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
📍 Baylor College of Medicine — Houston, Texas
Renal Cell Carcinoma
View Study & Checklist ➔Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
📍 M D Anderson Cancer Center — Houston, Texas
Malignant Neoplasms of Urinary Tract
View Study & Checklist ➔Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
📍 Research Site — Boston, Massachusetts
Papillary Renal Cell Carcinoma
View Study & Checklist ➔A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
📍 UC San Diego Moores Cancer Center — La Jolla, California
GIST
View Study & Checklist ➔Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Ciliary Body and Choroid Melanoma, Medium/Large Size
View Study & Checklist ➔ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
📍 University of Miami — Miami, Florida
Gastrointestinal Stromal Tumors
View Study & Checklist ➔Pan Tumor Rollover Study
📍 Local Institution - 0220 — Huntsville, Alabama
Cancer
View Study & Checklist ➔Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
📍 Cross Cancer Institute — Edmonton, Alberta
Lymphoma, Non-Hodgkin
View Study & Checklist ➔Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
📍 Research Facility — Phoenix, Arizona
GEP-NET
View Study & Checklist ➔Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Digestive System Neuroendocrine Tumor G1
View Study & Checklist ➔Losartan + Sunitinib in Treatment of Osteosarcoma
📍 Children's Hospital Los Angeles — Los Angeles, California
Osteosarcoma
View Study & Checklist ➔A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
📍 GSK Investigational Site — Phoenix, Arizona
Gastrointestinal Neoplasms
View Study & Checklist ➔A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Osteosarcoma
View Study & Checklist ➔Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Metastatic Pancreatic Neuroendocrine Tumor
View Study & Checklist ➔(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Advanced Gastrointestinal Stromal Tumors
View Study & Checklist ➔TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Lymphoma, Non-Hodgkin
View Study & Checklist ➔